Summary of the National Advisory Committee on Immunization (NACI) statement update on the recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants - Concepedia

Concepedia

Publication | Open Access

Summary of the National Advisory Committee on Immunization (NACI) statement update on the recommended use of palivizumab to reduce complications of respiratory syncytial virus infection in infants

DOI Full Paper Access

17

Citations

2

References

2022

Year

Dorothy Moore, Angela Sinilaité, April Killikelly

Canada Communicable Disease Report

Abstract

Updated NACI recommendations on use of PVZ for the prevention of complications of RSV in infants are now available.

References

	Year	Citations

Page 1